Nivolumab (Opdivo), a drug which was previously found useful in the treatment of lung cancer, has exhibited the ability to extend the...
Ahead of their presentations at the European Cancer Congress in Vienna, the New England of Journal of Medicine (NETB) has published two studies...
Researchers meeting at the annual American Society of Clinical Oncology conference in Chicago are hailing immunotherapy — the prevention or treatment of...
Researchers report that two new cancer immunotherapy drugs in development by Bristol-Myers Squibb and Merck that free the immune system to fight...